Auburndale, FL, United States of America

J Christopher Flaherty

This inventor holds 267 USPTO granted patents and 134 published patent applications, plus 1 CIPO patent and 22 EPO patents, primarily in Medical Devices (CPC class A61B18-1492). Top assignees: Medtronic Vascular, Inc., Rox Medical, Inc., Transvascular, Inc.. Active years: 1993-2024.

USPTO Granted Patents = 267 

% Patents Active = 74.9


 

Average Co-Inventor Count = 3.7

ph-index = 92

Forward Citations = 40,344(Granted Patents)

Forward Citations (Not Self Cited) = 38,952(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Bedford, MA (US) (1993)
  • Topsfield, CA (US) (2007 - 2012)
  • Topsfiled, MA (US) (2012)
  • San Clemente, CA (US) (2012)
  • Aurburndale, FL (US) (2017)
  • Los Altos, CA (US) (2000 - 2018)
  • Aburndale, FL (US) (2018)
  • Topsfield, MA (US) (1994 - 2021)
  • Middletown, RI (US) (2023)
  • Auburndale, FL (US) (2015 - 2024)
  • Nottingham, NH (US) (2024)
  • Taunton, MA (US) (2024)

Company Filing History:

goldMedal30 out of 1,006 
 
Medtronic Vascular, Inc.
 patents
silverMedal22 out of 30 
 
Rox Medical, Inc.
 patents
bronzeMedal22 out of 35 
 
Transvascular, Inc.
 patents
4. 21 out of 92 
 
Medtronic Ablation Frontiers LLC
 patents
5. 17 out of 242 
 
Insulet Corporation
 patents
6. 14 out of 19 
 
Medrobotics Corporation
 patents
7. 14 out of 17 
 
Neograft Technologies, Inc.
 patents
8. 13 out of 28 
 
Acutus Medical, Inc.
 patents
9. 13 out of 26 
 
Fractyl Health, Inc.
 patents
10. 13 out of 13 
 
Fractyl Laboratories, Inc.
 patents
11. 10 out of 10 
 
Braingate Co., LLC
 patents
12. 9 out of 11 
 
Lumen Devices, LLC
 patents
13. 7 out of 5,509 
 
Leland Stanford Junior University
 patents
14. 6 out of 1,959 
 
University of Pittsburgh
 patents
15. 6 out of 41 
 
Vertiflex, Inc.
 patents
16. 5 out of 704 
 
Hologic, Inc.
 patents
17. 4 out of 77 
 
Exactech, Inc.
 patents
18. 4 out of 4 
 
Strato/infusaid, Inc.
 patents
19. 4 out of 4 
 
Tissue Solutions, LLC
 patents
20. 3 out of 54 
 
Circulite Gmbh
 patents
21. 3 out of 12 
 
Functional Neuromodulation, Inc.
 patents
22. 2 out of 1,187 
 
Carnegie Mellon University
 patents
23. 2 out of 7 
 
Cryotherapeutics Gmbh
 patents
24. 2 out of 1,790 
 
Edwards Lifesciences Corporation
 patents
25. 2 out of 25 
 
Nalu Medical, Inc.
 patents
26. 2 out of 14 
 
Strato Medical Corporation
 patents
27. 2 out of 17 
 
Xeltis Ag
 patents
28. 1 out of 1,659 
 
Boston Scientific Neuromodulation Corporation
 patents
29. 1 out of 492 
 
Brown University
 patents
30. 1 out of 4 
 
Cser Ventures, LLC
 patents
31. 1 out of 9 
 
Gentuity, LLC
 patents
32. 1 out of 1 
 
Interlace Medical, Inc.
 patent
33. 1 out of 3 
 
Kibur Medical, Inc.
 patents
34. 1 out of 14 
 
Merlin MD Pte Ltd.
 patents
35. 1 out of 15 
 
Ninepoint Medical, Inc.
 patents
36. 1 out of 7 
 
Orchid Sound Technologies LLC
 patents
37. 1 out of 1 
 
Phase2 Microtechnologies, Inc.
 patent
38. 1 out of 1 
 
Programmable Pump Technologies, Inc.
 patent
39. 1 out of 1 
 
Securus Medical Group, Inc.
 patent
40. 1 out of 4 
 
Shanghai Wallaby Medical Technologies Co., Inc.
 patents
41. 1 out of 1 
 
Topsfield Medical Gmbh
 patent
42. 5 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tissue Ablation
Spine Treatment
Cardiac Analysis
Gastrointestinal Procedures
Sleep Apnea
Bioerodible Wraps
Neurology Probes
Therapeutic Restrictions
Artificial Fistula
Injectate Delivery
Stimulation Apparatus
Diabetes Treatment
267 patents (USPTO):Explore Patents

J. Christopher Flaherty is a well-known inventor with a knack for bringing innovative ideas to life. Based in Topsfield, MA, Flaherty has a whopping 233 patents to his name, making him a true pioneer in the field of inventions and patents.

His recent patents speak volumes about his ability to create groundbreaking, game-changing inventions that use state-of-the-art technology to change the world around us. One such patent is his Ultrasound sequencing system and method, which comprises a catheter configured for delivery to a body cavity defined by surrounding tissue, a plurality of ultrasound transducers coupled to a distal end of the catheter, and an electronics module configured to selectively turn on/off each ultrasound transducer according to a predetermined activation sequence. The system can process signals received from each ultrasound transducer to produce at least a 2D display of the surrounding tissue. A user can selectively calculate and display various aspects of cardiac activity. Moreover, the user can display Dipole Density (DDM), Charge Density (CDM), or Voltage (V-V). The shape and location of the chamber (surface), and the potentials recorded at electrodes can be displayed. The system can also change back and forth between the different display modes, and with post-processing tools, can change how various types of information is displayed.

Another one of Flaherty's patents is for methods, systems, and devices for reducing the luminal surface area of the gastrointestinal tract. These methods, systems, and devices for treating a patient include providing a tissue treatment element constructed and arranged to deliver energy to tissue and treating tissue of the gastrointestinal tract by causing the tissue treatment element to deliver energy to an energy delivery zone. Treatment results in a reduction in the luminal surface area of at least a portion of the gastrointestinal tract. In particular embodiments, the methods, systems and devices are used to treat diabetes.

Flaherty's contributions in the medical field have been nothing short of remarkable. He has worked for companies like ACUTUS MEDICAL, INC. and Fractyl Health, Inc., where he collaborated with talented individuals like Joshua Makower and Randell Louis Werneth.

It's clear that J. Christopher Flaherty has made a name for himself through his exceptional work in the field of inventions and patents. His contributions to the medical field have been truly remarkable. In fact, Flaherty's Ultrasound sequencing system and method and his methods, systems, and devices for reducing the luminal surface area of the gastrointestinal tract have the potential to revolutionize the medical industry as we know it.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…